Arcturus Therapeutics Holdings Inc ARCT Q1 2026 Earnings EPS Beat Narrowed Net Loss No Revenue Reported ASML Q1 2026 Earnings EPS Beats Estimates with 713 Surprise as Stock Holds Steady AREN Q1 2026 Earnings Significant EPS Miss Despite Share Price Uptick FMNB Q1 2026 Earnings Strong EPS Surprise of 212 Drives Investor Attention Despite Stock Dip IMMR Q3 2025 Earnings EPS Beat Drives Positive Market Reaction Licensing Revenue Remains Opaque Immunome IMNM Edges Higher as Stock Consolidates Near Key Resistance Level Helport AI Warrants HPAIW Slip 125 as Price Tests Critical Support at 004 Brookfield Infrastructure BIPC Holds Near Support Amid Modest Pullback Tectonic Therapeutic TECX Rallies 376 as Biotech Momentum Builds Key Levels to Watch Everlane Founder Michael Preysman Announces New Venture After Shein Acquisition Burford Capital Q1 2026 Earnings Substantial EPS Miss Reflects Volatility in Litigation Finance